BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27516211)

  • 21. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma.
    Ulrich D; Noah EM; von Heimburg D; Pallua N
    Plast Reconstr Surg; 2003 Apr; 111(4):1423-31. PubMed ID: 12618601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine Dilated Cardiomyopathy: Diffuse Remodeling, Focal Lesions, and the Involvement of Macrophages and New Vessel Formation.
    Gasparini S; Fonfara S; Kitz S; Hetzel U; Kipar A
    Vet Pathol; 2020 May; 57(3):397-408. PubMed ID: 32125251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients.
    Picard F; Brehm M; Fassbach M; Pelzer B; Scheuring S; Küry P; Strauer BE; Schwartzkopff B
    Clin Res Cardiol; 2006 May; 95(5):261-9. PubMed ID: 16598395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure.
    Koshman YE; Patel N; Chu M; Iyengar R; Kim T; Ersahin C; Lewis W; Heroux A; Samarel AM
    J Card Fail; 2013 Apr; 19(4):283-94. PubMed ID: 23582094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries.
    Lipczyńska M; Szymański P; Kumor M; Klisiewicz A; Hoffman P
    PLoS One; 2017; 12(8):e0180629. PubMed ID: 28767656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic adaptations of the extracellular matrix in dilated cardiomyopathy.
    Louzao-Martinez L; Vink A; Harakalova M; Asselbergs FW; Verhaar MC; Cheng C
    Int J Cardiol; 2016 Oct; 220():634-46. PubMed ID: 27391006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis.
    Klappacher G; Franzen P; Haab D; Mehrabi M; Binder M; Plesch K; Pacher R; Grimm M; Pribill I; Eichler HG
    Am J Cardiol; 1995 May; 75(14):913-8. PubMed ID: 7733000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients.
    Aharinejad S; Krenn K; Paulus P; Schäfer R; Zuckermann A; Grimm M; Abraham D
    Am J Transplant; 2005 Sep; 5(9):2185-92. PubMed ID: 16095497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy.
    Yokoseki O; Yazaki Y; Suzuki J; Imamura H; Takenaka H; Isobe M
    Jpn Circ J; 2000 May; 64(5):352-7. PubMed ID: 10834450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
    Antonov IB; Kozlov KL; Pal'tseva EM; Polyakova OV; Lin'kova NS
    Bull Exp Biol Med; 2018 Mar; 164(4):550-553. PubMed ID: 29504111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
    Kaye DM; Khammy O; Mariani J; Maeder MT
    Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology.
    Yilmaz Y; Eren F
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):43-46. PubMed ID: 30134384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal matrix remodeling in adolescents and young adults with Kawasaki disease late after onset.
    Lin MT; Chen SJ; Ho YL; Huang KC; Chen CA; Chiu SN; Sun LC; Lee WJ; Chen HC; Wang JK; Wu MH
    Clin Chem; 2008 Nov; 54(11):1815-22. PubMed ID: 18801939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease.
    Nakamura T; Ushiyama C; Suzuki S; Ebihara I; Shimada N; Koide H
    Am J Nephrol; 2000; 20(1):32-6. PubMed ID: 10644865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.